Weight loss research questions need for GLP-1 drugs
A new approach to weight loss research is challenging one of the biggest assumptions behind popular weight loss drugs: Are GLP-1s actually needed to achieve weight loss?
Apr 17, 2026
0
34
Endocrinology news
Diabetes flips immune cells from repair to inflammation in peripheral artery disease, study finds
Type 2 diabetes can turn immune cells that help with tissue repair and anti-inflammatory responses into triggers of chronic inflammation. A recent study investigated why people with type 2 diabetes are at a higher risk of ...
Triggering self-combustion in fat cells for weight loss
Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a preclinical study by Weill Cornell Medicine investigators. In the study, published in Nature Metabolism, ...
Feb 23, 2026
0
32
Metabolic health emerges as key to brain and memory problems in bipolar disorder
While they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major depressive disorder are distinct. A novel study appearing in Biological Psychiatry: Cognitive Neuroscience ...
May 17, 2026
0
32
Our body is doing fat-math (better than you'd imagine)
Remember seeing your triglyceride levels in your lab report? Ah! Fats you may dismiss, thinking of the next gym work you need to head to. Fatty acids are broken down via a process called β-oxidation. But did you ever wonder ...
GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression
GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons, a new study shows. The large register-based study was carried out ...
Mar 18, 2026
0
31
GLP-1 drugs may protect the heart beyond weight loss, trial results suggest
With the use of GLP-1 medications on the rise, cardiologists are seeing benefits to heart health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a class of drugs that act ...
Feb 10, 2026
0
30
Sleep‑aligned fasting improves key heart and blood‑sugar markers
A new Northwestern Medicine study has personalized overnight fasting by aligning it with individuals' circadian sleep-wake rhythm—an important regulator of cardiovascular and metabolic function—without changing their caloric ...
Feb 12, 2026
0
30
Low vitamin D levels linked to 33% higher risk of hospitalization for severe respiratory infections
Severe vitamin D deficiency is associated with a higher rate of hospitalization for respiratory tract infections such as bronchitis and pneumonia, according to a new study led by the University of Surrey. Scientists found ...
Jan 21, 2026
0
30
New GLP-1 pill orforglipron outperforms oral semaglutide in yearlong diabetes trial
A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 randomized controlled trial ...
Feb 26, 2026
0
30
